UpdatesGeneral Updates
IOL Chemicals is expanding its Ibuprofen capacity by 6,000 MTPA to 18,000 MTPA with a ₹350 Cr investment.
IOL Chemicals and Pharmaceuticals LimitedIOLCP · Filed with the exchange
It is also entering the CDMO formulation space with a ₹110 Cr facility and establishing a dedicated specialty chemicals plant for ₹35 Cr, entirely funded via internal accruals.
No comments yet. Be the first.